Follow us on LinkedIn for updates:
Day 3 spotlights the dynamic intersection of biotech innovation and investment, exploring how scientific breakthroughs are translated into real-world solutions. The day features sessions on bioengineering, the microbiome, food technologies, and university-driven entrepreneurship, alongside key discussions on commercialization, investor perspectives, and tech transfer pathways. With insights from leading scientists, entrepreneurs, and investors, the agenda emphasizes how biotech is evolving at the crossroads of discovery, impact, and capital.
Chair: Grigoris Amoutzias, Professor, Bioinformatics in Microbiology, University of Thessaly, Greece
Irini Angelidaki, Professor, Technical University of Denmark, Denmark
Title: Microbial Consortia Powering the Green Biotech Revolution
Petros Giannikopoulos, Director, Interventional Genomics Unit, Innovative Genomics Institute, USA
Title: TBD
Vasilis Ntziachristos, Professor of Medicine and Electrical Engineering, Chair of Biological Imaging, Technical University of Munich Germany
Title: Bioengineering as the engine of clinical translation and healthcare economy.
Chris Mason, Professor of Genomics, Physiology & Biophysics at Weill Cornell Medicine, USA
Title: Planetary-scale genomics and interplanetary biology plans
Startup Chair: TBD
TBD x6
VC Panel Chair: Leda Kourita, Physician, Entrepreneur, Investor, & Associate Partner, BioInnovation Greece, USA
Cassandra Kosmidou, Investment Manager at Big Pi Ventures, Greece
TBD
Chair: Antigoni Dimas, Group Leader at IFBR - BSRC “Alexander Fleming”, Greece
Antigoni Dimas, Group Leader at IFBR - BSRC “Alexander Fleming”, Greece
Title: When meat leaves the menu: the molecular consequences of animal product dietary restriction
Yiannis Kourmpetis, Founder & CEO Siftlink, Switzerland
Title: What If Fermentation Was the Future of Personalized Nutrition?
Kalliopi Gkouskou, Assistant Professor at Medical School NKUA & Co-Founder, CEO GENOSOPHY, Greece
Title: From Genes to Solutions: Bridging Genomic Innovation with Public Health Impact
Nikos Scarmeas, Professor of Neurology, NTUA, and Associate Professor of Neurology Columbia University, Greece
Title: Nutrition and Cognition: multidimensional complexity related challenges.
Startup Chair: TBD
TBD x6
VC Panel Chair: TBD
TBD
John Ioannidis, Professor of Medicine, Epidemiology, Population Health and of Biomedical Data Science, Stanford University, USA
Title: The scientific literature under threat: bias, QRPs, fraud, AI, activism, and politics
Chair: TBD
Ioannis Kotsiopoulos, General Manager @ Pharma Innovation Forum (PIF), Greece
Ioannis Xenarios, CTO, TwinEdge Bioscience, Head of Data Analysis Platform at Health2030 Genome Center, Professor at CHUV, Switzerland
Vakchos Leskaselis, Marketing Manager & UI/UX Lead at Gnomon Informatics SA, Greece
TBD
Moderator: Anna Grimani, Journalist, Author, Greece
Featured Guest: Joseph Sifakis, Research Director VERIMAG, France
Chair: Victoria Kimonides, Director, Insaitu Ltd. & Associate Partner, BioInnovation Greece, Greece
Fay Christodoulou, Chief Scientific Officer, Microfluidics, INTEGRA Biosciences, USA
Nektarios (Aris) Oraiopoulos, Professor at Cambridge Judge Business School, UK
George Georgiou, Professor, Dula D. Cockrell Centennial Chair in Engineering, U. Texas, Austin, USA
TBD
Chair: TBD
TBD
Chair: TBD
Maria Markidou Georgiadou, Managing Director at Cyprus Seeds, Cyprus
Nikolaos Milonas, Academic Advisor, Archimedes Center for Innovation and Entrepreneurship, Greece
Arianna Ioannidou, Community Manager, egg – enter grow go, Eurobank, Greece
Demetrios Mallios, Founder/CEO, Aeon Group of Companies , Greece